ARSENIC PENTOXIDE | SODIUM DICHROMATE - search results

arsenicum album 3ch-30ch globules tablet

boiron laboratoires - arsenic trioxide - tablet - 3ch - arsenic trioxide 3ch - homeopathic products

United States - English - NLM (National Library of Medicine)

guna-pms- arsenic trioxide - estradiol - goldenseal - lachesis muta venom - magnesium phosphate - matricaria recutita - melatoni

guna spa - arsenic trioxide (unii: s7v92p67ho) (arsenic cation (3+) - unii:c96613f5av), estradiol (unii: 4ti98z838e) (estradiol - unii:4ti98z838e), goldenseal (unii: zw3z11d0jv) (goldenseal - unii:zw3z11d0jv), lachesis muta venom (unii: vsw71ss07i) (lachesis muta venom - unii:vsw71ss07i), magnesium phosphate, tribasic, pentahydrate (unii: 453cof7817) (magnesium cation - unii:t6v3lhy838), matricaria recutita (unii: g0r4ubi2zz) (matricaria recutita - unii:g0r4ubi2zz), melatonin (unii: jl5dk93rcl) (melatonin - uni - arsenic trioxide 6 [hp_c] in 30 ml - arsenicum album 6c mood support beta-estradiol 6x vaginal dryness chamomilla 6c calming hydrastis canadensis 6c analgesic hypophysis 8x hormonal regulation lachesis mutus 4c anxiety magnesia phosphorica 6c metabolic support melatonin 4c hormonal balance nux vomica 6c mood support oophorinum 8x irregular menses progesterone 6x irregular menses sulfur 6c detoxification temporary relief of symptoms due to premenstrual syndrome such as: - moodiness - cramping - backache take 15 minutes before meals

Australia - English - Department of Health (Therapeutic Goods Administration)

phenasen arsenic trioxide 10 mg/10 ml injection vial

phebra pty ltd - arsenic trioxide, quantity: 1 mg/ml - injection, concentrated - excipient ingredients: water for injections; hydrochloric acid; sodium hydroxide - for the induction of remission and consolidation in patients with acute promyelocytic leukaemia (apl) who are refractory to, or have relapsed from, retinoid and anthracycline chemotherapy, and whose apl is characterised by the presence of the t(15:17) translocation or pml/rar-alpha gene expression. for the induction of remission and consolidation in patients with previously untreated acute promyelocytic leukaemia (apl), in combination with all-trans retinoic acid (atra) and/or chemotherapy and whose apl is characterised by the presence of the t(15:17) translocation or pml/rar-alpha gene expression.